https://depositphotos.com/photos
Jul 24, 2025, 16:06
A New Online Tool is Helping Doctors Better Predict Relapse Risk in Early-Stage Hodgkin Lymphoma
Manchester Cancer Research Centre shared on LinkedIn:
“A new online tool is helping doctors better predict relapse risk in early-stage Hodgkin lymphoma.
Developed by researchers at The University of Manchester, The Christie NHS Foundation Trust, and US partners, the E-HIPI calculator is the first of its kind. It uses real patient data – like tumour size, haemoglobin, and albumin levels – to estimate the likelihood of relapse within two years.
It is hoped this new tool can allow doctors to personalise treatment plans, reduce unnecessary side effects, and closely monitor patients at higher risk or relapse.”
More posts featuring Hodgkin Lymphoma.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 25, 2025, 17:20
Jul 25, 2025, 16:55
Jul 25, 2025, 16:50
Jul 25, 2025, 16:46
Jul 25, 2025, 16:40
Jul 25, 2025, 16:12
Jul 25, 2025, 16:06